These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 38817601)

  • 21. Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo.
    Kitaura H; Kimura K; Ishida M; Kohara H; Yoshimatsu M; Takano-Yamamoto T
    Clin Dev Immunol; 2013; 2013():181849. PubMed ID: 23762085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD39 Produced from Human GMSCs Regulates the Balance of Osteoclasts and Osteoblasts through the Wnt/β-Catenin Pathway in Osteoporosis.
    Wu W; Xiao Z; Chen Y; Deng Y; Zeng D; Liu Y; Huang F; Wang J; Liu Y; Bellanti JA; Rong L; Zheng SG
    Mol Ther; 2020 Jun; 28(6):1518-1532. PubMed ID: 32304668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay between interferon and other cytokine systems in bone metabolism.
    Takayanagi H; Sato K; Takaoka A; Taniguchi T
    Immunol Rev; 2005 Dec; 208():181-93. PubMed ID: 16313349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoimmunology: The Regulatory Roles of T Lymphocytes in Osteoporosis.
    Zhang W; Dang K; Huai Y; Qian A
    Front Endocrinol (Lausanne); 2020; 11():465. PubMed ID: 32849268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taking a toll on the bones: regulation of bone metabolism by innate immune regulators.
    Bar-Shavit Z
    Autoimmunity; 2008 Apr; 41(3):195-203. PubMed ID: 18365832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide and bone.
    Evans DM; Ralston SH
    J Bone Miner Res; 1996 Mar; 11(3):300-5. PubMed ID: 8852940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice.
    Yang P; Lv S; Wang Y; Peng Y; Ye Z; Xia Z; Ding G; Cao X; Crane JL
    Bone; 2018 Sep; 114():1-13. PubMed ID: 29800693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Def6 regulates endogenous type-I interferon responses in osteoblasts and suppresses osteogenesis.
    Deng Z; Ng C; Inoue K; Chen Z; Xia Y; Hu X; Greenblatt M; Pernis A; Zhao B
    Elife; 2020 Dec; 9():. PubMed ID: 33373293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoclasts: more than 'bone eaters'.
    Charles JF; Aliprantis AO
    Trends Mol Med; 2014 Aug; 20(8):449-59. PubMed ID: 25008556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of notch signaling in osteoimmunology--from the standpoint of osteoclast differentiation.
    Duan L; Ren Y
    Eur J Orthod; 2013 Apr; 35(2):175-82. PubMed ID: 22423182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.
    Wang L; Liu S; Zhao Y; Liu D; Liu Y; Chen C; Karray S; Shi S; Jin Y
    Cell Death Differ; 2015 Oct; 22(10):1654-64. PubMed ID: 25744024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frontline Science: Human bone cells as a source of IL-27 under inflammatory conditions: role of TLRs and cytokines.
    Larousserie F; Bsiri L; Dumaine V; Dietrich C; Audebourg A; Radenen-Bussière B; Anract P; Vacher-Lavenu MC; Devergne O
    J Leukoc Biol; 2017 Jun; 101(6):1289-1300. PubMed ID: 27677834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paget's disease of bone: an osteoimmunological disorder?
    Numan MS; Amiable N; Brown JP; Michou L
    Drug Des Devel Ther; 2015; 9():4695-707. PubMed ID: 26316708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoclast-Primed Foxp3+ CD8 T Cells Induce T-bet, Eomesodermin, and IFN-γ To Regulate Bone Resorption.
    Shashkova EV; Trivedi J; Cline-Smith AB; Ferris C; Buchwald ZS; Gibbs J; Novack D; Aurora R
    J Immunol; 2016 Aug; 197(3):726-35. PubMed ID: 27324129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The osteoimmunology of alveolar bone loss.
    Tompkins KA
    Connect Tissue Res; 2016; 57(2):69-90. PubMed ID: 26950207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoimmunology.
    Rauner M; Sipos W; Pietschmann P
    Int Arch Allergy Immunol; 2007; 143(1):31-48. PubMed ID: 17191007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.
    Baum R; Gravallese EM
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):1-15. PubMed ID: 26411424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoimmunology--the hidden immune regulation of bone.
    Caetano-Lopes J; Canhão H; Fonseca JE
    Autoimmun Rev; 2009 Jan; 8(3):250-5. PubMed ID: 18722561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover.
    Cheng CH; Chen LR; Chen KH
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.